New ‘buyers’ club’ sells unapproved cancer drug

A new buyers’ club is importing a groundbreaking breast cancer drug that is unapproved in Australia despite fast-track approval in the US and Europe.

Netherlands-based The Social Medwork is offering Ibrance (palbociclib) at 125mg and 75mg doses for over A$10,000 per packet, excluding shipping costs.

The company’s co-founder, Sjaak Vink, says the company is using the TGA’s personal